Unlock instant, AI-driven research and patent intelligence for your innovation.

A kind of thienopyrimidinone thioglycolic acid derivative and its preparation method and application

A technology for pyrimidone thioglycolic acid derivatives and its derivatives, which is applied in the field of thienopyrimidinone thioglycolic acid derivatives and their preparation, and can solve problems such as poor effect and toxic side effects

Active Publication Date: 2021-05-28
SHANDONG UNIV
View PDF9 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, the clinically used drugs for the treatment of gout and hyperuricemia mainly include anti-inflammatory drugs, uric acid production inhibitors mainly based on xanthine oxidase inhibitors, and uricosuric drugs. There are serious toxic and side effects, which greatly limit the clinical use

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of thienopyrimidinone thioglycolic acid derivative and its preparation method and application
  • A kind of thienopyrimidinone thioglycolic acid derivative and its preparation method and application
  • A kind of thienopyrimidinone thioglycolic acid derivative and its preparation method and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0044] Embodiment 1. Preparation of intermediate 1-cyclopropyl-4-isothiocyanatonaphthalene (b)

[0045] Preparation of intermediate 4-cyclopropyl-1-naphthylamine (a):

[0046] The raw material 4-bromo-1-naphthylamine (3.0g, 13.50mmol) was mixed with cyclopropylboronic acid (1.5g, 17.55mmol) and placed in a 250mL double-necked bottle, and then K was added to the bottle. 3 PO 4 (10.2g, 47.10mmol), tetrakistriphenylphosphine palladium (1.5g, 1.35mmol), after mixing, add about 60mL toluene and 5mL water as solvent, seal, carry out N 2protection, 100°C heating and reflux reaction for 12h; TLC monitoring, after the reaction was completed, the reaction solution was cooled to room temperature, filtered, washed with ethyl acetate (20mL×3), the filtrate was collected, and then the filtrate was dried to obtain a dark brown residue. Add about 30 mL of water to the residue, extract with ethyl acetate (40 mL×3), combine the organic phases, add an appropriate amount of anhydrous magnesium ...

Embodiment 2

[0050] Example 2. Preparation of intermediate 3-(4-cyclopropylnaphthalen-1-yl)-2-mercaptothieno[3,2-d]pyrimidin-4(3H)-one (I-1a)

[0051] Intermediate b (0.507g, 2.25mmol) and methyl 3-aminothiophene-2-carboxylate (0.307g, 1.95mmol) were dissolved in 20mL of absolute ethanol, and heated under reflux at 90°C for 4h; TLC monitoring showed that the reaction was complete After cooling to room temperature, crystals were precipitated, filtered, and the filter cake was taken, then added a small amount of ethanol for recrystallization, filtered to remove the solid, then added 30mL 2mol / L KOH solution, heated to reflux at 90°C until the compound was dissolved, stopped heating, cooled to room temperature, At this time, a small amount of floc was precipitated, and then the pH was adjusted to about 3 with 3mol / L HCl, and a large amount of white solid was precipitated. At this time, it was slowly filtered, washed with water (10mL×2), and dried to obtain intermediate I-1a, which was White s...

Embodiment 3

[0052] Example 3. Intermediate 3-(4-cyclopropylnaphthalen-1-yl)-2-mercapto-7-methylthieno[3,2-d]pyrimidin-4(3H)-one (I-1b ) preparation

[0053] Intermediate b (0.224g, 0.99mmol) and reactant 3-amino-5-methylthiophene-2-carboxylate (0.135g, 0.79mmol) were dissolved in about 5mL of pyridine solution, heated at 45°C for 12h, TLC monitoring, after the reaction is complete, cool to room temperature, add about 40mL of ice water, then extract with dichloromethane (40mL×3), combine the organic phases, dry over anhydrous magnesium sulfate, filter, take the filtrate, evaporate to dryness, and use 30mL of 1% NaOH solution was heated to reflux at 90°C for 12h, cooled to room temperature, filtered, and the filtrate was taken, and the pH was adjusted to about 3 with 1mol / L hydrochloric acid, a large amount of white solid was precipitated, filtered, and the filter cake was washed with water, The intermediate I-1b was obtained as a white solid with a yield of 53.0%; melting point: >250°C; ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
melting pointaaaaaaaaaa
melting pointaaaaaaaaaa
melting pointaaaaaaaaaa
Login to View More

Abstract

The invention relates to a thienopyrimidinone thioglycolic acid derivative, a preparation method and application thereof. The compound has the structure shown in formula I or II. The present invention also relates to a preparation method and a pharmaceutical composition containing the compound of formula I or II. The present invention also provides the application of the above compound in the preparation of anti-gout medicine.

Description

technical field [0001] The invention belongs to the technical field of organic compound synthesis and medical application, and specifically relates to a thienopyrimidinone thioglycolic acid derivative and a preparation method and application thereof. Background technique [0002] Gout is a metabolic disease caused by increased production or decreased excretion of uric acid due to purine metabolic disorders, and the formation of monosodium urate crystals deposited in joint tissues. Hyperuricemia is its main clinical manifestation. The end product of purine metabolism in the body is uric acid, and hyperuricemia is a metabolic disease caused by abnormal purine metabolism in the body. In recent decades, the number of patients with gout and hyperuricemia has been increasing worldwide, which has seriously affected the quality of life of human beings and brought a heavy burden to society. my country is a country with a high incidence of gout, and the number of gout patients is abo...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07D495/04A61P19/06A61K31/519
CPCA61P19/06C07D495/04
Inventor 刘新泳艾炜展鹏庞建新吴婷孙卓森赵彤张健董悦梁瑞鹏
Owner SHANDONG UNIV